Diseases, Conditions, Syndromes

High demand for at-home COVID tests could hamper supply

(HealthDay)—Demand for Abbott Laboratories' at-home COVID-19 tests has reached "unprecedented" levels and supply may be limited in the coming weeks, the company says.

Vaccination

World mulls next step as US backs IP waiver on vaccines

Activists cheered, Big Pharma complained and government leaders assessed next steps on Thursday after the Biden administration's blockbuster move to support an easing of patent and other protections on COVID-19 vaccines that ...

page 7 from 21